Aenitis annonce un f
Aenitis annonce un financement stratégique pour redéfinir les standards de la bioproduction grâce à sa technologie unique d’acoustofluidique
October 10, 2024 02:00 ET | Aenitis Technologies
Aenitis annonce un financement stratégique pour redéfinir les standards de la bioproduction grâce à sa technologie unique d’acoustofluidique Aenitis est en passe de transformer la...
Aenitis-logo.png
Aenitis Secures Strategic Funding to Redefine Bioproduction with Sole-In-Class Acoustofluidic Technology
October 10, 2024 02:00 ET | Aenitis Technologies
Aenitis Secures Strategic Funding to Redefine Bioproduction with Sole-In-Class Acoustofluidic Technology Aenitis is set to transform the bioproduction industry by addressing the increasing...
Pieridae logo_Hunter.jpg
Pieridae Announces Closing of Equity Rights Offering
October 08, 2024 12:48 ET | Pieridae Alberta Production Ltd.
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES ORDISSEMINATION IN UNITED STATES CALGARY, Alberta, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Pieridae Energy Limited (“Pieridae” or the “Company”)...
Heliene Logo.jpg
Heliene Partners With Transition Equity Partners to Expand Domestic Solar Manufacturing Capacity
October 07, 2024 08:00 ET | Heliene, Inc.; Transition Equity Partners
MOUNTAIN IRON, Minn., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Heliene Inc., a leading North American solar PV module manufacturer, is pleased to announce closing a strategic equity investment up to $54...
K4-MA-SE-TX-L1.jpg
Keiretsu Forum Announces Dr. Martin Gershon as Keynote Speaker for 2024 Investor Capital Expo
October 02, 2024 07:08 ET | Keiretsu Forum Mid-Atlantic
This signature event in early-stage investment community will be held on October 31, 2024, at Convene City View in Philadelphia.
Mabylon AG Receives Research Grants Totaling More Than CHF 1.3 Million for Amyotrophic Lateral Sclerosis (ALS) and Inflammasome Programs
September 24, 2024 04:00 ET | AKAMPION
Schlieren, Zurich/Switzerland, September 24, 2024 - Mabylon AG, a leader in the high-throughput discovery, characterization, and development of human-derived antibodies, today announced that it has...
Yamaha OAI 2024 Infographic
Yamaha Outdoor Access Initiative Awards Over $170,000 in Second Quarter Grants to Rebuild OHV Trails Affected by Natural Disasters
September 19, 2024 15:00 ET | Yamaha Motor Corp., USA
MARIETTA, Ga., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Yamaha Motor Corp., USA, awarded more than $170,000 in grants through its Yamaha Outdoor Access Initiative (OAI) in the second quarter of 2024,...
LQS_Logo_Horizontal_YellowBlack_0821.png
LiquidStack Secures $20 Million from Tiger Global to Bring Liquid Cooling to AI Data Centers on a Global Scale
September 19, 2024 09:00 ET | LiquidStack
CARROLLTON, Texas, Sept. 19, 2024 (GLOBE NEWSWIRE) -- LiquidStack, a global leader in liquid cooling for data centers, today announced that it has secured a $20 million Series B extension investment...
tiziana-logo.png
Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease
September 19, 2024 07:00 ET | Tiziana Life Sciences Ltd.
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
Vaccinex logo
Vaccinex Announces Exercise of Warrants for $6.2 Million in Gross Proceeds
September 18, 2024 08:30 ET | Vaccinex, Inc.
ROCHESTER, N.Y., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a differentiated approach to...